美瑞健康國際(02327.HK)將額外使用最多6900萬港元以進一步進行股份購回
格隆匯3月28日丨美瑞健康國際(02327.HK)公吿,於2022年3月28日,董事會決定繼續動用股份購回授權,將額外使用最多6900萬港元的資金總額以進一步進行建議股份購回,並視市況不定期於公開市場購回股份,故此,董事會已授權但未動用作為回購股份的資金最高總額合共約1億港元。公司將從現有可動用現金儲備及自由現金流量為購回撥付資金。
董事會認為,股份購回既基於對業務前景的信心,也將為其股東創造價值。董事會認為,公司現金流良好,足以支持股份購回和業務發展。同時,集團將充分利用其積累的醫療機構運營、產品研發、品牌及客户優勢,積極拓展皮膚健康管理的業務,有效結合功效護膚品和醫美治療以提升客户體驗。董事會對集團的未來充滿信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.